# An Efficacy and Safety Study of DFL24498 in the Treatment of AKC

> **NCT07395232** · PHASE3 · RECRUITING · sponsor: **Dompé Farmaceutici S.p.A** · enrollment: 138 (estimated)

## Conditions studied

- Atopic Keratoconjunctivitis

## Interventions

- **DRUG:** DFL24498
- **DRUG:** Vehicle
- **DRUG:** dexamethasone sodium phosphate (DSP) ophthalmic solution

## Key facts

- **NCT ID:** NCT07395232
- **Lead sponsor:** Dompé Farmaceutici S.p.A
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2027-03
- **Final completion:** 2027-05
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07395232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07395232, "An Efficacy and Safety Study of DFL24498 in the Treatment of AKC". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07395232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*